MELISSA WEBSTER: Open Payments
NPI 1245974419 · RADCLIFF, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,430 in 79 payments from 18 companies in 2025. Trend: 2023 $1,023 · 2024 $1,138 · 2025 $1,430
Food & beverage: $1,430
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $301 |
| Novo Nordisk Inc | 17 | $241 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $191 |
| Insulet Corporation | 7 | $139 |
| Exact Sciences Corporation | 4 | $81 |
| Astellas Pharma US Inc | 3 | $73 |
| Axsome Therapeutics, Inc. | 4 | $73 |
| Amgen Inc. | 5 | $73 |
| Lilly USA, LLC | 4 | $62 |
| Dynavax Technologies Corporation | 2 | $37 |
Products named: CAPLYTA, QULIPTA, Omnipod, Wegovy, VRAYLAR, Cologuard Collection Kit, Veozah, Auvelity.
Industry payments across KY — which companies pay providers there.
